Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (201-210 of 528) with videos related to

Pageof 53
Sort By:
Cellular Signalling|August 11, 2007
Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherinYutong Zhao, Donghong He, Randi Stern, et al.
Biochemical Pharmacology|January 9, 2020
SOX9: The master regulator of cell fate in breast cancerSamir Jana, B Madhu Krishna, Jyotsana Singhal, et al.
Oncotarget|June 15, 2018
Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical modelsRavi Salgia, Isa Mambetsariev, Blake Hewelt, et al.
Current Opinion in Systems Biology|June 11, 2020
Opportunities for improving cancer treatment using systems biologyJason I Griffiths, Adam L Cohen, Veronica Jones, et al.
Science Advances|June 18, 2025
Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domainSupriyo Bhattacharya, Yanan He, Yihong Chen, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 30, 2013
Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier functionYutong Zhao, Jing Zhao, Rachel K Mialki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
c-Met is a potentially new therapeutic target for treatment of human melanomaNeelu Puri, Salman Ahmed, Varalakshmi Janamanchi, et al.
Clinical and Translational Medicine|October 9, 2018
Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockadeJun Gong, Andrew Hendifar, Richard Tuli, et al.
Clinical Lung Cancer|August 13, 2024
RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung CancerAmanda Reyes, Michelle Afkhami, Erminia Massarelli, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 19, 2023
Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancersPankaj Garg, Atish Mohanty, Sravani Ramisetty, et al.
Pageof 53

Showing results (201-210 of 528) with videos related to

Sort By:
Pageof 53
Cellular Signalling|August 11, 2007
Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherinYutong Zhao, Donghong He, Randi Stern, et al.
Biochemical Pharmacology|January 9, 2020
SOX9: The master regulator of cell fate in breast cancerSamir Jana, B Madhu Krishna, Jyotsana Singhal, et al.
Oncotarget|June 15, 2018
Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical modelsRavi Salgia, Isa Mambetsariev, Blake Hewelt, et al.
Current Opinion in Systems Biology|June 11, 2020
Opportunities for improving cancer treatment using systems biologyJason I Griffiths, Adam L Cohen, Veronica Jones, et al.
Science Advances|June 18, 2025
Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domainSupriyo Bhattacharya, Yanan He, Yihong Chen, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 30, 2013
Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier functionYutong Zhao, Jing Zhao, Rachel K Mialki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
c-Met is a potentially new therapeutic target for treatment of human melanomaNeelu Puri, Salman Ahmed, Varalakshmi Janamanchi, et al.
Clinical and Translational Medicine|October 9, 2018
Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockadeJun Gong, Andrew Hendifar, Richard Tuli, et al.
Clinical Lung Cancer|August 13, 2024
RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung CancerAmanda Reyes, Michelle Afkhami, Erminia Massarelli, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 19, 2023
Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancersPankaj Garg, Atish Mohanty, Sravani Ramisetty, et al.
Pageof 53